National Center for Advancing and Translational Sciences Genetic and Rare Diseases Information Center, a program of the National Center for Advancing and Translational Sciences

Specific antibody deficiency



Other Names:
Immunodeficiency due to selective anti-polysaccharide antibody deficiency; Impaired polysaccharide responsiveness; Selective antibody deficiency with normal immunoglobulins; Immunodeficiency due to selective anti-polysaccharide antibody deficiency; Impaired polysaccharide responsiveness; Selective antibody deficiency with normal immunoglobulins; Partial antibody deficiency See More
Categories:

The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.
orphanet

Orpha Number: 70593

Definition
Immunodeficiency due to selective anti-polysaccharide antibody deficiency is characterized by normal immunoglobulin levels (including IgG sub-classes) but impaired polysaccharide responsiveness (IPR).

Epidemiology
Although the prevalence is not really known, around 100 cases have been reported in the literature, indicating that this syndrome is a rare primary immunodeficiency. Approximately 60% of patients are male.

Clinical description
The onset of the disease generally occurs during childhood, between 2 to 7 years of age. Patients suffer from recurrent bacterial infections, mostly of the respiratory tract. The offending bacteria are those with a polysaccharide capsule, such as pneumococci, Hemophilus influenzae, meningococci and group B streptococci. Sepsis and meningitis occur less frequently. Allergic manifestations are observed in half of the patients.

Etiology
This immunodeficiency is likely heterogeneous with multiple causes. Genetic factors may play a role, as indicated by the observation of a higher prevalence in certain ethnic populations and of some familial cases. Several hypotheses have been proposed concerning the cause of the disease, but the most likely is a defect in splenic marginal zone B cells. Indeed, polysaccharide antigens are concentrated and presented to B cells by the dendritic cells within the spleen marginal zone. In favour of this hypothesis is the observation of an impaired polysaccharide antibody response in splenectomized patients.

Diagnostic methods
The diagnosis is established by identifying deficient antibody response to polysaccharide antigens (usually Haemophilus influenzae b vaccine) contrasting with normal immunoglobulin (including the IgG subclasses) levels and unaffected antibody production to protein antigens (tetanus toxoid, diphtheria). As most children under 2 years of age have a physiological defect in response to polysaccharide antigens, the diagnosis cannot be assessed before this age.

Differential diagnosis
The differential diagnosis should exclude other primary immunodeficiencies also characterized by a defective response to polysaccharide antigens, essentially the IgG2-IgG4 deficiency. A defect in antibody production to polysaccharides may be associated with the Wiskott-Aldrich syndrome or Common Variable Immuno Deficiency (CVID). Recently, an adult patient with Btk-deficiency has been reported as only affected by impaired polysaccharide responsiveness.

Management and treatment
Besides their use for controlling infections, antibiotics should also be given as a prophylactic treatment. Immunoglobulin substitution could also be of benefit whenever prophylactic antibiotherapy fails. Vaccination with the conjugate antipneumococcal vaccine is also required.

Prognosis
Under treatment, infections are generally well controlled. However, patients should be carefully followed-up since this condition can evolve into a more severe immunodeficiency (IgG subclass deficiency or CVID).

Visit the Orphanet disease page for more resources.
Last updated: 10/1/2006

Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

Patient Registry


These resources provide more information about this condition or associated symptoms. The in-depth resources contain medical and scientific language that may be hard to understand. You may want to review these resources with a medical professional.

In-Depth Information

  • Medscape Reference provides information on this topic. You may need to register to view the medical textbook, but registration is free.
  • The Monarch Initiative brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch’s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.
  • Orphanet is a European reference portal for information on rare diseases and orphan drugs. Access to this database is free of charge.

Questions sent to GARD may be posted here if the information could be helpful to others. We remove all identifying information when posting a question to protect your privacy. If you do not want your question posted, please let us know.